Melatonin has been reported to alleviate ALI in vivo and in vitro by inhibiting NLRP3-GSDMD pathway through activating Nrf2/HO-1 signaling pathway [66]. The gene discussed is NFE2L2; the disease is acute respiratory distress syndrome.